IFOM Alberto Bardelli Lab

Alberto Bardelli Lab

Alberto Bardelli

Alberto Bardelli is Director of Laboratory Molecular Oncology at the Candiolo Cancer Institute IRCCS - Candiolo (Torino) and Associate Professor at the Dept. of Oncology, University of Turin. read more

Contact the researcher

Genomics of Cancer and Targeted Therapies

In the past 15 years it has become clear that cancer has a genetic basis and that mutations affecting the coding sequences of specific genes are the hallmark of this disease. This knowledge has already had a dramatic impact in the clinical arena. read more

Laboratory location: Turin, Italy

Recent publications

  • Kwak EL, Ahronian LG, Siravegna G, Mussolin B, Godfrey JT, Clark JW, Blaszkowsky LS, Ryan DP, Lennerz JK, Iafrate AJ, Bardelli A, Hong TS, Corcoran RB.
    Molecular heterogeneity and receptor co-amplification drive resistance to targeted therapy in MET-amplified esophagogastric cancer.
    Cancer Discov. 2015 Oct 2. pii: CD-15-0748. [Epub ahead of print]
  • Prahallad A, Heynen GJJE, Germano G, Willems SM, Evers B, Vecchione L, Gambino V, Lieftink C, Beijersbergen RL, Di Nicolantonio F, Bardelli A, Bernards R
    PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs
    Cell Reports. 2015 Sep 29;12(12):1978-85
  • Misale S, Bozic I, Tong J, Peraza-Penton A, Lallo A, Baldi F, Lin KH, Truini M, Trusolino L, Bertotti A, Di Nicolantonio F, Nowak MA, Zhang L, Wood KC and Bardelli A
    Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
    Nat Commun. 2015 Sep 22;6:8305

Group members

Postoctoral Fellow
Nabil Amirouchene Angelozzi
Sabrina Arena
Giorgio Corti
Giovanni Crisafulli
Giovanni Germano
Luca Lazzari
Annalisa Lorenzato
Mariangela Russo
Beth Van Emburgh
PhD student
Giulia Siravegna
Alessandro Magrí
Research technologist
Luca Novara
Giuseppe Rospo
Simona Lamba
Monica Montone
Alice Bartolini
Michela Buscarino
Carlotta Cancelliere
Benedetta Mussolin